reported that inhibition of NRF2 increased lenvatinib sensitivity and lipid ROS levels in HCC cells.[90] Further, estrogen‐related receptor (ERR) expression was remarkably increased in HCC tissues, which was associated with increased cell proliferation. The gene discussed is SLC7A1; the disease is hepatocellular carcinoma.